4//SEC Filing
VICURON PHARMACEUTICALS INC 4
Accession 0001181431-05-007963
CIK 0001052547operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:15 PM ET
Size
20.1 KB
Accession
0001181431-05-007963
Insider Transaction Report
Form 4
HORNER GEORGE F III
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2005-02-07$18.21/sh−800$14,564→ 40,750 total - Sale
Common Stock
2005-02-07$18.01/sh−23,500$423,235→ 13,250 total - Sale
Common Stock
2005-02-07$18.05/sh−2,000$36,105→ 49,250 total - Sale
Common Stock
2005-02-07$18.00/sh−10,000$180,000→ 51,250 total - Sale
Common Stock
2005-02-07$18.14/sh−3,700$67,118→ 43,550 total - Exercise/Conversion
Stock Option
2005-02-07+50,000→ 147,044 totalExercise: $0.40Exp: 2007-12-08→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 24, 2004.
- [F2]Subject to continued service, the option vests as to 25% of the underlying shares 12 months after the date of grant and the balance of 75% vests in 36 equal monthly installments commencing 13 months after the date of grant.
Documents
Issuer
VICURON PHARMACEUTICALS INC
CIK 0001052547
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001052547
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 8:15 PM ET
- Size
- 20.1 KB